approach for tibial CTOs; and group 3, retrograde approach for femoropopliteal and tibial CTOs.
IP199. Outcomes After Open and Endovascular Treatment of Infrainguinal Occlusive Disease in Morbidly Obese and Superobese Patients
Objective: Although the effect of body mass index on the treatment of infrainguinal peripheral arterial disease (PAD) has been analyzed, outcomes of patients on the high end of the spectrum of morbid obesity (MO; body mass index >40) and superobesity (SO) are unclear. Our goal was to analyze perioperative outcomes of infrainguinal PAD after lower extremity bypass (LEB) and peripheral vascular interventions (PVI) in this population of patients.
Methods: The Vascular Quality Initiative was reviewed for all infrainguinal PAD interventions from 2010 to 2017. Patient and case details were recorded. Multivariable analysis was used to analyze outcomes.
Results: We identified 30,389 LEB cases (69.8% nonobese, 27.1% obese, 2.8% MO, 0.33% SO) and 84,649 PVI cases (67.9% nonobese, 28.1% obese, 3.5% MO, 0.52% SO). For LEB and PVI, MO and SO patients were younger, more often female, less often with smoking history, more often on Medicaid, and more often ambulatory; they more often had diabetes, end-stage renal disease, and congestive heart failure, with fewer previous inflow procedures (P < .05 for all). LEB and PVI interventions in MO and SO patients were less often elective and more often for tissue loss. For LEB, MO and SO patients more often had greater saphenous vein used as conduit and had popliteal artery origin grafts (P < .05). In PVI, MO and SO patients more often had tibial interventions (P < .05). Multivariable analysis showed that MO and SO after LEB were not associated with increased perioperative cardiac complications, return to operating room, primary patency, and mortality (Table). MO was associated with increased surgical site infection. Multivariable analysis showed that MO and SO after LEB were not associated with periprocedural access site hematoma, access site stenosis/ occlusion, and mortality (Table) .
Conclusions: MO and SO were not independently associated with increased major adverse outcomes after LEB and PVI, aside from surgical site infections after LEB. Overall, MO and SO patients have more comorbidities and have more advanced presentation. MO and SO alone should not deter appropriate revascularization. Objective: Lower extremity fasciotomies after reperfusion in patients with acute lower extremity ischemia are occasionally performed prophylactically to reduce the risk of limb loss due to compartment syndrome, yet there are few data to support this practice. In this study, we compared amputation rates and other outcomes after emergent lower extremity embolectomy with and without concurrent fasciotomy.
Methods: A retrospective analysis was performed using prospectively collected data in the National Surgical Quality Improvement Program for patients undergoing emergent arterial lower extremity embolectomy between 2011 and 2016. Preoperative characteristics and 30-day outcomes were compared for patients who underwent lower extremity embolectomy with and without fasciotomy at the index operation. Multivariable regression was performed to establish independent predictors of outcomes. 
